Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
Saudi Arabia
· Delayed Price · Currency is SAR 39.38
+0.28 (0.72%)
Aug 14, 2025, 3:19 PM AST
TADAWUL:4017 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 2,969 | 2,791 | 2,327 | 2,012 | 1,965 | 1,715 | Upgrade
|
| Revenue Growth (YoY) | 14.82% | 19.95% | 15.62% | 2.43% | 14.53% | 4.57% | Upgrade
|
| Cost of Revenue | 2,264 | 2,092 | 1,710 | 1,412 | 1,327 | 1,199 | Upgrade
|
| Gross Profit | 705.33 | 699.04 | 616.68 | 600.35 | 637.82 | 516.51 | Upgrade
|
| Selling, General & Admin | 359.11 | 337.69 | 292.49 | 177.23 | 173.35 | 198.82 | Upgrade
|
| Other Operating Expenses | -10.44 | -11.19 | -21.14 | -12.36 | - | - | Upgrade
|
| Operating Expenses | 369.97 | 339.98 | 282.7 | 218.3 | 261.4 | 236.43 | Upgrade
|
| Operating Income | 335.37 | 359.06 | 333.98 | 382.05 | 376.41 | 280.08 | Upgrade
|
| Interest Expense | -41.64 | -95.67 | -122.15 | -55.94 | -34.79 | -46.16 | Upgrade
|
| Interest & Investment Income | 29.78 | 23.67 | 42.88 | 24.88 | 6.17 | 8.49 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 17.55 | 9.08 | Upgrade
|
| EBT Excluding Unusual Items | 323.51 | 287.07 | 254.71 | 351 | 365.34 | 251.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.13 | - | - | Upgrade
|
| Pretax Income | 323.51 | 287.07 | 254.71 | 351.12 | 365.34 | 251.49 | Upgrade
|
| Income Tax Expense | 27.88 | 23.4 | 22.69 | 20.44 | 4.56 | 26.65 | Upgrade
|
| Earnings From Continuing Operations | 295.63 | 263.67 | 232.02 | 330.68 | 360.78 | 224.84 | Upgrade
|
| Minority Interest in Earnings | 26.06 | 23.88 | 47.58 | -4.37 | -26.5 | -21.66 | Upgrade
|
| Net Income | 321.69 | 287.55 | 279.6 | 326.32 | 334.28 | 203.18 | Upgrade
|
| Net Income to Common | 321.69 | 287.55 | 279.6 | 326.32 | 334.28 | 203.18 | Upgrade
|
| Net Income Growth | 17.48% | 2.85% | -14.32% | -2.38% | 64.53% | -32.60% | Upgrade
|
| Shares Outstanding (Basic) | 230 | 217 | 200 | 200 | 100 | 100 | Upgrade
|
| Shares Outstanding (Diluted) | 230 | 217 | 200 | 200 | 100 | 100 | Upgrade
|
| Shares Change (YoY) | 13.80% | 8.59% | - | 100.00% | - | - | Upgrade
|
| EPS (Basic) | 1.40 | 1.32 | 1.40 | 1.63 | 3.34 | 2.03 | Upgrade
|
| EPS (Diluted) | 1.40 | 1.32 | 1.40 | 1.63 | 3.34 | 2.03 | Upgrade
|
| EPS Growth | 3.23% | -5.29% | -14.32% | -51.19% | 64.53% | - | Upgrade
|
| Free Cash Flow | -226.39 | -43.7 | 32.31 | -138.23 | 174.63 | -60.07 | Upgrade
|
| Free Cash Flow Per Share | -0.98 | -0.20 | 0.16 | -0.69 | 1.75 | -0.60 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | - | - | - | - | Upgrade
|
| Gross Margin | 23.75% | 25.05% | 26.50% | 29.83% | 32.46% | 30.11% | Upgrade
|
| Operating Margin | 11.29% | 12.87% | 14.35% | 18.98% | 19.16% | 16.33% | Upgrade
|
| Profit Margin | 10.83% | 10.30% | 12.02% | 16.21% | 17.02% | 11.84% | Upgrade
|
| Free Cash Flow Margin | -7.62% | -1.57% | 1.39% | -6.87% | 8.89% | -3.50% | Upgrade
|
| EBITDA | 444 | 460.52 | 428.55 | 451.31 | 437.29 | 339.26 | Upgrade
|
| EBITDA Margin | 14.95% | 16.50% | 18.42% | 22.43% | 22.26% | 19.78% | Upgrade
|
| D&A For EBITDA | 108.64 | 101.45 | 94.57 | 69.26 | 60.88 | 59.17 | Upgrade
|
| EBIT | 335.37 | 359.06 | 333.98 | 382.05 | 376.41 | 280.08 | Upgrade
|
| EBIT Margin | 11.29% | 12.87% | 14.35% | 18.98% | 19.16% | 16.33% | Upgrade
|
| Effective Tax Rate | 8.62% | 8.15% | 8.91% | 5.82% | 1.25% | 10.60% | Upgrade
|
| Advertising Expenses | - | 26.29 | 31.72 | 5.74 | 11.66 | 6 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.